2022
DOI: 10.1371/journal.ppat.1010743
|View full text |Cite
|
Sign up to set email alerts
|

Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes

Abstract: The tripartite motif (TRIM) family of E3 ubiquitin ligases is well known for its roles in antiviral restriction and innate immunity regulation, in addition to many other cellular pathways. In particular, TRIM25-mediated ubiquitination affects both carcinogenesis and antiviral response. While individual substrates have been identified for TRIM25, it remains unclear how it regulates diverse processes. Here we characterized a mutation, R54P, critical for TRIM25 catalytic activity, which we successfully utilized t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
17
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 91 publications
2
17
0
Order By: Relevance
“…3XFLAG-ZAPS and -ZAPL were amplified from the pcDNA3.1-3XFLAG plasmids using primers to add ClaI and NotI restriction sites for ligation into the ePB vector (gift from Dr. Ali Brivanlou, Rockefeller University) (31). Full-length TRIM25 (gift from Dr. Jae U. Jung at Cleveland Clinic Lerner Research Institute) (49) was cloned into pcDNA3.1-myc as previously described (50). ZAP positive selection mutants were generated by the Q5 Site-Directed Mutagenesis Kit (New England Biolabs, Ipswich, MA) or synthesized as a gene block (Twist Bioscience, South San Francisco, CA) with ClaI and NotI restriction sites and ligated into the ePB vector.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…3XFLAG-ZAPS and -ZAPL were amplified from the pcDNA3.1-3XFLAG plasmids using primers to add ClaI and NotI restriction sites for ligation into the ePB vector (gift from Dr. Ali Brivanlou, Rockefeller University) (31). Full-length TRIM25 (gift from Dr. Jae U. Jung at Cleveland Clinic Lerner Research Institute) (49) was cloned into pcDNA3.1-myc as previously described (50). ZAP positive selection mutants were generated by the Q5 Site-Directed Mutagenesis Kit (New England Biolabs, Ipswich, MA) or synthesized as a gene block (Twist Bioscience, South San Francisco, CA) with ClaI and NotI restriction sites and ligated into the ePB vector.…”
Section: Methodsmentioning
confidence: 99%
“…1µg/mL puromycin was added 48 hours post-transfection to select for ZAP KO 293T cells that have incorporated the ePB transposon. Our ZAPS WT and ZAPL WT cell lines were made by selecting single cell clones that follow two criteria: 1) robustly express ZAP following 24 hours of 1µg/mL doxycycline treatment, and 2) recapitulate differential alphaviral sensitivities (S3 Fig) similar to previously generated bulk cell lines with inducible ZAP expression (7,50). The mutant ZAP cell lines in this study were bulk cells that survived after puromycin selection.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The infectious clone plasmids of enhanced GFP (EGFP)-expressing or unlabeled CHIKV (vaccine strain 181/clone 25), EGFP-expressing or unlabeled ONNV (strain SG650), EGFP-expressing SINV (TE/5'2J/GFP), and EGFP-expressing RRV (strain T48) have been previously reported [67][68][69][70][71] . Propagations and titrations of virus stocks were generated in BHK-21 cells as previously described 72,73 . To infect THP-1 derived macrophages or primary monocyte derived macrophages, viruses were diluted in DPBS supplemented with 1% human AB serum (Omega Scientific) and 1% P/S, and added to cells at a multiplicity of infection (MOI) of 5 plaque-forming units (PFU)/cell.…”
Section: Methodsmentioning
confidence: 99%
“…Dysregulated protein abundance and quality control is central to nearly all human diseases, spanning cardiovascular disease 1,2 , cancer [3][4][5] , neurodegeneration [6][7][8] , and viral infections 9,10 . The latter is particularly noteworthy given both the recent COVID-19 pandemic and the preponderance of mechanisms by which host proteostasis processes are co-opted by pro-viral factors [11][12][13][14][15] . Consequently, the development of pharmacological agents that modulate protein homeostasis is a burgeoning area for both functional biology and drug development.…”
Section: Introductionmentioning
confidence: 99%